Lite Strategy (LITS) Research & Development (2010 - 2026)
Lite Strategy (LITS) reported Research & Development of $36,000 for fiscal Q4 2026 (quarter ended Jun 30, 2026), down 56.6% from $83,000 a year earlier but up 20.0% from the prior quarter.
Powered by 
Analysis
Lite Strategy (LITS) Research & Development (2010 - 2026) Analysis & Trends
For FY2026 (ended Jun 30, 2026), Lite Strategy posted Research & Development of $122,000, down 96.9% from FY2025.
- Research & Development has declined for four consecutive fiscal years, with a five-year compound annual growth rate of -71.9% (FY2021 to FY2026).
- By fiscal year, Research & Development came in at $3.92 million in FY2025 (-76.3%), $16.56 million in FY2024 (-68.4%), $52.45 million in FY2023 (-38.8%) and $85.64 million in FY2022 (+23.4%).
- Five-year quarterly Research & Development spans a low of $10,000 in fiscal Q1 2026 and a high of $22.32 million in fiscal Q3 2022.
- Year over year, Research & Development has now declined in each of the last eight quarters, with an average decline of 78.2% over the last eight quarters.
- The high point for year-over-year Research & Development in five years was fiscal Q1 2022 (growth of 53.5%); the low point was fiscal Q1 2026 (a decline of 99.7%).
- Per Business Quant data, the three fiscal quarters before Q4 2026 came in at $30,000 (Q3 2026), $46,000 (Q2 2026) and $10,000 (Q1 2026).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,158.92 Bn | 1,127.51 Bn | 19.71 Bn | 3.82 Bn |
| 2 | Johnson & Johnson | 624.53 Bn | 543.05 Bn | 17.26 Bn | 3.65 Bn |
| 3 | AbbVie | 511.96 Bn | 485.07 Bn | 12.70 Bn | 2.34 Bn |
| 4 | Merck | 366.03 Bn | 320.41 Bn | 12.21 Bn | 9.74 Bn |
| 5 | Novartis Ag | 297.25 Bn | 261.24 Bn | 11.24 Bn | 2.85 Bn |
| 6 | Astrazeneca | 261.04 Bn | 234.72 Bn | 12.86 Bn | 4.05 Bn |
| 7 | Amgen | 234.72 Bn | 190.12 Bn | 7.24 Bn | 1.87 Bn |
| 8 | Gilead Sciences | 193.91 Bn | 168.11 Bn | 6.22 Bn | 1.76 Bn |
| 9 | Pfizer | 171.65 Bn | 118.30 Bn | 10.94 Bn | 2.81 Bn |
| 10 | Lite Strategy | 41.47 Mn | 9.35 Mn | - | 36,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 36,000.00 |
| Mar 31, 2026 | 30,000.00 |
| Dec 31, 2025 | 46,000.00 |
| Sep 30, 2025 | 10,000.00 |
| Jun 30, 2025 | 83,000.00 |
| Mar 31, 2025 | 369,000.00 |
| Dec 31, 2024 | 308,000.00 |
| Sep 30, 2024 | 3.16 Mn |
| Jun 30, 2024 | 3.94 Mn |
| Mar 31, 2024 | 5.22 Mn |
| Dec 31, 2023 | 3.91 Mn |
| Sep 30, 2023 | 3.49 Mn |
| Jun 30, 2023 | 2.57 Mn |
| Mar 31, 2023 | 15.10 Mn |
| Dec 31, 2022 | 15.31 Mn |
| Sep 30, 2022 | 19.46 Mn |
| Jun 30, 2022 | 21.84 Mn |
| Mar 31, 2022 | 22.32 Mn |
| Dec 31, 2021 | 21.53 Mn |
| Sep 30, 2021 | 19.95 Mn |
API Access
Lite Strategy Research & Development API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=research-and-development&ticker=LITS&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "research-and-development", "ticker": "LITS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=research-and-development&ticker=LITS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();